Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT00755833
Eligibility Criteria:
Inclusion Criteria:
* Type 2 diabetes treated with biphasic human insulin with or without metformin
* Inadequate glycaemic control or is experiencing hypoglycaemic events or would, in the physician's opinion, benefit from treatment with NovoMix® 50
Exclusion Criteria:
* Subjects with diagnosed type 1 diabetes mellitus
* Subjects treated with short acting or intermediate acting human insulin or any insulin analogue
* Subjects who are unlikely to comply with study description, e.g. uncooperative attitude, inability to come for regular visits
* Subjects with a hypersensitivity to biphasic insulin aspart 50 (NovoMix® 50 )or to any of the excipients
* Women of childbearing potential, who are pregnant, breast-feeding or intend to become pregnant within next 12 months
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00755833
Study Brief:
Protocol Section:
NCT00755833